Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs Procter & Gamble Co (PG) Price & Performance

Intuitive Surgical, Inc.Trade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs Procter & Gamble Co — how do they compare? Intuitive Surgical, Inc. trades at $344.9 (market cap $122.33B), while Procter & Gamble Co trades at $149.78 (market cap $349.24B). The key difference: Procter & Gamble Co is far larger — about 2.9× Intuitive Surgical, Inc.'s market cap, and Procter & Gamble Co pays a 2.9% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

ISRGPG
Market Cap
$122.33B$349.24B
Sector
HealthConsumer Staples
52-Week High
$592.85$167.18
52-Week Low
$345.42$138.10
Enterprise Value
$113.71B$374.72B
Volume
6,423,436
Dividend Yield
2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) is trading at $345.42, down 14.15% after Q2 2026 earnings beat estimates but disappointed investors with a tepid full-year procedure growth outlook. The stock is near its 52-week low of $344.55, with bearish technical signals from moving averages. Fundamentally, the company maintains strong profitability with 28.45% net income margin and has beaten EPS estimates for three consecutive quarters. Revenue growth remains robust, climbing from $6.2B in 2022 to $10.1B in 2025.

The investment outlook is mixed: strong fundamentals and a $504.56 analyst price target suggest long-term value, but near-term risks include slowing U.S. procedure growth, insurance headwinds, and bearish technical momentum. The stock offers potential for recovery if procedure growth accelerates, but faces volatility from sentiment shifts and competitive pressures in robotic surgery.

Procter & Gamble Co

Procter & Gamble (PG) trades at $149.96, down 1.0% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company maintains strong fundamentals with consistent earnings beats, robust cash flow generation, and a 69-year dividend growth history. Recent quarterly results exceeded expectations, though valuation multiples remain at premium levels compared to industry peers.

PG offers stability through consistent execution and shareholder returns, but faces challenges from premium valuation and modest growth outlook. The stock presents a defensive investment opportunity with reliable income, though upside may be limited until valuation aligns more closely with growth prospects or operational improvements accelerate.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG